O'Shaughnessy Asset Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

O'Shaughnessy Asset Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.3K	Sell	188 -131	-41%	-$14.2K	﹤0.01%	2368
2026 Q1	$33.1K	Buy	319 +281	+739%	+$29.7K	﹤0.01%	2290
2025 Q4	$3.97K	Buy	+38	New	+$3.82K	﹤0.01%	2500
2021 Q4	–	Sell	-909	Closed	-$70K	–	2144
2021 Q3	$70K	Hold	909	–	–	﹤0.01%	1520
2021 Q2	$73K	Hold	909	–	–	﹤0.01%	1435
2021 Q1	$72K	Buy	+909	New	+$70.9K	﹤0.01%	1304

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

O'Shaughnessy Asset Management's PJP Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its Invesco Pharmaceuticals ETF (PJP) stake by 41% in Q2 2026, selling an estimated $14.2K and leaving 188 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2368.

O'Shaughnessy Asset Management first reported a position in PJP in Q1 2021 and has held it in 6 quarters since. The position peaked at $73K in Q2 2021. 116 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

O'Shaughnessy Asset Management held 188 shares of Invesco Pharmaceuticals ETF worth $22.3K as of Q2 2026.
O'Shaughnessy Asset Management sold 131 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $14.2K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #2368 holding.
O'Shaughnessy Asset Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2021 and has held it in 6 quarters since.
O'Shaughnessy Asset Management's Invesco Pharmaceuticals ETF position peaked at $73K in Q2 2021.
116 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.